- Home
- ESNT vs VANI Comparison
ESNT vs VANI Comparison
Compare ESNT & VANI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ESNT
- VANI
- Stock Information
- Founded
- ESNT 2008
- VANI 1998
- Country
- ESNT Bermuda
- VANI United States
- Employees
- ESNT N/A
- VANI N/A
- Industry
- ESNT Property-Casualty Insurers
- VANI Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Sector
- ESNT Finance
- VANI Health Care
- Exchange
- ESNT Nasdaq
- VANI Nasdaq
- Market Cap
- ESNT N/A
- VANI 68.1M
- IPO Year
- ESNT 2013
- VANI 2014
- Fundamental
- Price
- ESNT $61.90
- VANI $1.26
- Analyst Decision
- ESNT Buy
- VANI Strong Buy
- Analyst Count
- ESNT 7
- VANI 1
- Target Price
- ESNT $63.29
- VANI $4.00
- AVG Volume (30 Days)
- ESNT 693.7K
- VANI 146.6K
- Earning Date
- ESNT 08-01-2025
- VANI 08-12-2025
- Dividend Yield
- ESNT 2.00%
- VANI N/A
- EPS Growth
- ESNT 3.49
- VANI N/A
- EPS
- ESNT 6.84
- VANI N/A
- Revenue
- ESNT $1,262,105,000.00
- VANI N/A
- Revenue This Year
- ESNT $5.40
- VANI N/A
- Revenue Next Year
- ESNT $3.66
- VANI N/A
- P/E Ratio
- ESNT $9.05
- VANI N/A
- Revenue Growth
- ESNT 9.57
- VANI N/A
- 52 Week Low
- ESNT $51.61
- VANI $0.91
- 52 Week High
- ESNT $65.34
- VANI $1.50
- Technical
- Relative Strength Index (RSI)
- ESNT 65.63
- VANI 58.97
- Support Level
- ESNT $60.34
- VANI $1.24
- Resistance Level
- ESNT $62.02
- VANI $1.33
- Average True Range (ATR)
- ESNT 1.06
- VANI 0.06
- MACD
- ESNT 0.19
- VANI 0.00
- Stochastic Oscillator
- ESNT 97.53
- VANI 59.09
About VANI Vivani Medical Inc. (DE)
Vivani Medical Inc is a preclinical-stage biopharmaceutical company. The company develops miniaturized, subdermal implants utilizing its proprietary NanoPortal technology to enable long-term, near-constant-rate delivery of a broad range of medicines to treat chronic diseases. It has two reporting segments, the Biopharm Division and the Neuromodulation Division. The Biopharm Division includes activities from NPM and Vivani Medical Australia Pty Ltd, and the Neurostimulation Division includes activities from Cortigent and its subsidiary in Switzerland.